BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23531648)

  • 21. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis.
    Song TW; Sohn MH; Kim ES; Kim KW; Kim KE
    Clin Exp Allergy; 2006 Mar; 36(3):346-51. PubMed ID: 16499646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis.
    Kwakkel-van Erp JM; Haeck IM; Paantjens AW; van de Graaf EA; van Ginkel WG; Knol MJ; de Bruin-Weller MS; Lammers JW; Knol EF; Bruijnzeel-Koomen C; Otten HG
    J Am Acad Dermatol; 2010 Sep; 63(3):e70-2. PubMed ID: 20708466
    [No Abstract]   [Full Text] [Related]  

  • 23. [Objective measurements of disease severity and diagnostic confirmation in atopic dermatitis and urticaria].
    Mihara S
    Arerugi; 2012 Jan; 61(1):10-7. PubMed ID: 22398423
    [No Abstract]   [Full Text] [Related]  

  • 24. Significant correlation of serum IL-22 levels with CCL17 levels in atopic dermatitis.
    Hayashida S; Uchi H; Takeuchi S; Esaki H; Moroi Y; Furue M
    J Dermatol Sci; 2011 Jan; 61(1):78-9. PubMed ID: 21095106
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum Thymus and Activation Regulated Chemokine (TARC), IL- 18 and IL-18 Gene Polymorphism as Associative Factors with Atopic Dermatitis.
    Gohar MK; Atta AH; Nasr MM; Hussein DN
    Egypt J Immunol; 2017 Jun; 24(2):9-22. PubMed ID: 29528575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infantile atopic dermatitis: Serum vitamin D, zinc and TARC levels and their relationship with disease phenotype and severity.
    Esenboga S; Cetinkaya PG; Sahiner N; Birben E; Soyer O; Sekerel BE; Sahiner UM
    Allergol Immunopathol (Madr); 2021; 49(3):162-168. PubMed ID: 33938202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
    Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Asahina A; Onai N; Matsushima K; Tamaki K
    J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum thymus and activation-regulated chemokine as disease activity and response biomarker in alopecia areata.
    Inui S; Noguchi F; Nakajima T; Itami S
    J Dermatol; 2013 Nov; 40(11):881-5. PubMed ID: 24102731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children.
    Mostafa GA; Tomoum HY; Salem SA; Abd El-Aziz MM; Abou El-Maged DI; El-Sayed El-Far I
    Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decrease in circulating Th17 cells correlates with increased levels of CCL17, IgE and eosinophils in atopic dermatitis.
    Hayashida S; Uchi H; Moroi Y; Furue M
    J Dermatol Sci; 2011 Mar; 61(3):180-6. PubMed ID: 21255981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy.
    Kwon YS; Oh SH; Wu WH; Bae BG; Lee HJ; Lee MG; Lee KH
    Exp Dermatol; 2010 Mar; 19(3):246-51. PubMed ID: 19758316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Relationship Between Serum TARC, TSLP and POSTN Levels and Childhood Atopic Dermatitis.
    Uysal P; Birtekocak F; Karul AB
    Clin Lab; 2017 Jul; 63(7):1071-1077. PubMed ID: 28792717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients.
    Thijs JL; Drylewicz J; Fiechter R; Strickland I; Sleeman MA; Herath A; May RD; Bruijnzeel-Koomen CAFM; Knol EF; Giovannone B; de Bruin-Weller MS; Nierkens S; Hijnen DJ
    J Allergy Clin Immunol; 2017 Dec; 140(6):1703-1705. PubMed ID: 28823810
    [No Abstract]   [Full Text] [Related]  

  • 34. A group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: possible immunological state of the intrinsic type.
    Kabashima-Kubo R; Nakamura M; Sakabe J; Sugita K; Hino R; Mori T; Kobayashi M; Bito T; Kabashima K; Ogasawara K; Nomura Y; Nomura T; Akiyama M; Shimizu H; Tokura Y
    J Dermatol Sci; 2012 Jul; 67(1):37-43. PubMed ID: 22591815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of thymus and activation-regulated chemokine as a marker of severity of atopic dermatitis.
    Himadri ; George R; Mathew L; Shanmugam V; Mani T; Jeyaseelan L
    J Am Acad Dermatol; 2021 Feb; 84(2):545-547. PubMed ID: 32439469
    [No Abstract]   [Full Text] [Related]  

  • 36. Case of atopic dermatitis concurrent with idiopathic thrombocytopenic purpura, whose serum thymus and activation-regulated chemokine level remained undetectable.
    Ozawa M; Sasahara Y; Aiba S
    J Dermatol; 2018 May; 45(5):606-608. PubMed ID: 29399856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis.
    Morita E; Takahashi H; Niihara H; Dekio I; Sumikawa Y; Murakami Y; Matsunaka H
    Allergy; 2010 Sep; 65(9):1166-72. PubMed ID: 20374230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conjunctivitis in patients with atopic dermatitis treated with dupilumab is associated with higher baseline serum levels of immunoglobulin E and thymus and activation-regulated chemokine but not clinical severity in a real-world setting.
    Uchida H; Kamata M; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Am Acad Dermatol; 2020 May; 82(5):1247-1249. PubMed ID: 31884090
    [No Abstract]   [Full Text] [Related]  

  • 39. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.
    Shimada Y; Takehara K; Sato S
    J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of inpatient treatment for atopic dermatitis evaluated by changes in serum cortisol levels.
    Fukuda H; Suzuki T; Saotome A; Sode E; Mukai H
    J Dermatol; 2013 Jan; 40(1):43-7. PubMed ID: 23039140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.